Swedish Cancer Society grants SEK 33,5 million to MedH researchers

Evren Alici, Hematology Unit/HERM
Title: iPSC-Derived Natural Killer Cell Therapies and modulation of host immune escape. 
Amount granted for 2024-2026: 2 400 000 SEK.

Annika Bergquist, Gastroenterology and Rheumatology Unit
Title: Studier av diagnostiska och prognostiska markörer och effekt av statinbehandling vid primär skleroserande kolangit – en premalign sjukdom.
Amount granted for 2024-2026: 3 000 000 SEK.

Niklas Björkström, Center for Infectious Medicine (CIM)
Title: Dissecting tissue resident lymphocyte homeostasis in human cancer.
Amount granted for  2024-2026: 4 500 000 SEK.

Yenan Bryceson, Hematology Unit/HERM
Title: Understanding and harnessing lymphocyte cytotoxicity against cancer.
Amount granted for 2024-2026: 5 250 000 SEK.

Benedict Chambers, Center for Infectious Medicine (CIM)
Title: Adhesion molecule JAML in anti-tumor immune responses.
Amount granted for 2024-2026: 2 400 000 SEK.

Sten Eirik Jacobsen, Hematology Unit/HERM
Title: Surveillance and targeting of cancer stem cells in myeloid dysplastic syndromes.
Amount granted for 2024-2026: 3 750 000 SEK.

Hans-Gustaf Ljunggren, Center for Infectious Medicine (CIM)
Title: Cancer immunotherapy: Fate of ex vivo expanded autologous NK cells following adoptive transfer to patients with hematological malignancies.
Amount granted for 2024-2025: 2 500 000 SEK.

Jakob Michaelsson, Center for Infectious Medicine (CIM)
Title: Dissecting the functional regulation of lung tumor infiltrating human NK Cells.
Amount granted for 2024-2026: 3 000 000 SEK.

Hong Qian, Hematology Unit/HERM
Title: Identifying potential therapeutic targets in microenvironment to overcome drug resistance and relapse in chronic myeloid leukemia.
Amount granted for 2024-2026: 3 750 000 SEK.

Johan Sandberg, Center for Infectious Medicine (CIM)
Title: The potential of innate-like MAIT cells in cancer: Immunobiology, tissue-specific specialization and immunotherapy.
Amount granted for 2024-2026: 3 000 000 SEK.